MyFinsight
Home
About
Contact
lyel: the income statement
Download
Download image
Comprehensive loss
-$38,702K
(10.88%↑ Y/Y)
Net unrealized gain
(loss) on marketable...
$144K
(-87.55%↓ Y/Y)
Net loss
-$38,846K
(12.87%↑ Y/Y)
Total other (loss)
income, net
-$1,593K
(-126.90%↓ Y/Y)
Loss from operations
-$37,253K
(26.24%↑ Y/Y)
Interest income, net
$3,266K
(-45.25%↓ Y/Y)
Revenue
$15K
(-55.88%↓ Y/Y)
Other (expense)
income, net
-$4,859K
(-11200.00%↓ Y/Y)
Total operating
expenses
$37,268K
(-26.26%↓ Y/Y)
Other operating
income, net
$1,591K
(117.95%↑ Y/Y)
General and
administrative
$10,687K
(-9.19%↓ Y/Y)
Research and development
$28,172K
(-28.68%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)